Abstracts tagged "Disparities"

Abstract Number: 0439 • ACR Convergence 2020
Hurried Communication and Low Patient Self-Efficacy Are Associated with Persistent Non-Adherence to SLE Medications
Ann Cameron Barr¹, Megan Clowse², Amanda Eudy³, Jennifer Rogers⁴, Rebecca Sadun³, Lisa Criscione-Schreiber⁵, Jayanth Doss³, Lena Eder⁶, Mithu Maheswaranathan³, Amy Corneli⁷, Hayden Bosworth⁷ and Kai Sun³, ¹Duke University Hospital, Durham, NC, ²Duke University, Chapel Hill, NC, ³Duke University, Durham, NC, ⁴Duke, Durham, NC, ⁵Duke University School of Medicine, Durham, NC, ⁶Duke University Hospital, Chapel Hill, NC, ⁷Duke University, Durham
Background/Purpose: Medication non-adherence is common among SLE patients and contributes to poor outcomes. Underrepresented racial minorities have disproportionately lower rates of medication adherence and often…
Abstract Number: 1986 • ACR Convergence 2020
Determinants of Variation in Pediatric Systemic Lupus Erythematosus Care Delivery
Jon Burnham¹, Rosemary Peterson¹, Joy Ukaigwe¹, Lynsey Cecere¹, Andrea Knight² and Joyce Chang¹, ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²Division of Rheumatology, The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, ON, Canada
Background/Purpose: Patients with pediatric systemic lupus erythematosus (pSLE) receive only a fraction of recommended care. Moreover, variation in care delivery likely contributes to pervasive racial…
Abstract Number: 0043 • ACR Convergence 2020
Geographical Disparity in Rheumatoid Arthritis Disease Burden Independent of Race/Ethnicity
Gail Kerr¹, Christopher Swearingen², Manuela Pedra-Nobre³, Dianne Wollaston⁴, Sawsan Najmey⁵, Cynthia Lawrence-Elliott⁶, Theresa Lawrence Ford⁶, Sharon Dowell⁷, Heather North⁸, Robin Dore⁹, Soha Dolatabadi¹⁰, Thaila Ramanujam¹¹, Anne Winkler¹², Stacy Kennedy¹³, Ilona Jileaeva¹⁴, Amina Richardson¹⁵, Jeffrey Kaine¹⁶ and Grace Wright¹⁷, ¹Washington DC VA Medical Center, Washington, DC, ²New York University, New York, NY, ³North Jersey Rheumatology Center, Westfield, NJ, ⁴Memorial Advanced Rheumatology, Inc, HOUSTON, TX, ⁵Midstate Rheumatology Center, Freehold, NJ, ⁶North Georgia Rheumatology Group, Lawrenceville, GA, ⁷Howard University, Washington, DC, ⁸Pardee UNC Rheumatology, Hendersonville, NC, ⁹Private practice, Tustin, CA, ¹⁰Soha Dolatabadi, MD, Los Angeles, CA, ¹¹Thaila Ramanujanm. M.D Inc, Santa Cruz, CA, ¹²Cox Medical Center, Springfield, MO, ¹³Rowan Diagnostic Clinic, Concord, NC, ¹⁴Howard University Hospital, Washington, DC, ¹⁵Howard University College of Medicine, Washington, DC, ¹⁶Sarasota Arthritis Center, Sarasota, FL, ¹⁷Association of Women in Rheumatology, New York, NY
Background/Purpose: In the US, health care systems vary, as does cost sharing and access to various RA therapies. However, the burden of RA – a…
Abstract Number: 0441 • ACR Convergence 2020
Use of an Integrated Care Management Program to Uncover and Address Social Determinants of Health for Individuals with Lupus
Kreager Taber¹, Jessica Williams¹, Weixing Huang², Katherine McLaughlin¹, Christine Vogeli³, Rebecca Cunningham¹, Lisa Wichmann¹ and Candace Feldman⁴, ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, ³Massachusetts General Hospital, Boston, MA, ⁴Brigham and Women's Hospital, Boston
Background/Purpose: The burden of systemic lupus erythematosus (SLE) falls disproportionately on racial/ethnic minorities and individuals of lower socioeconomic status who often receive fragmented, inconsistent care.…
Abstract Number: PP12 • ACR Convergence 2020
COVID-19, Racism, and Gender Discrimination: The Function of Stress in Widening the Gap in Health Disparities
Carly Harrison¹ and Christele Felix², ¹LupusChat, Richmond, VA, ²LupusChat, Rosedale, NY
Background/Purpose: Populations experiencing rheumatic diseases are often at higher risk of increased levels of stress. This may result in disease complications and can potentially lead…
Abstract Number: 0044 • ACR Convergence 2020
Characterization of Racial Disparities in Rheumatoid Arthritis Treatment Choice and Location of Care
Elston He¹, Eli Cornblath², Pratyusha Yalamanchi³, Alexis Ogdie², Joshua Baker² and Michael George², ¹Synovium, Inc., Philadelphia, PA, ²University of Pennsylvania, Philadelphia, PA, ³Michigan Medicine, Ann Arbor, MI
Background/Purpose: Racial disparities in access to care and treatment regimens exist but remain poorly characterized in the rheumatoid arthritis (RA) patient population. Previous studies using…
Abstract Number: 0442 • ACR Convergence 2020
Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate
Maria Antonelli¹ and Nora Singer², ¹MHMC/CWRU, Cleveland, OH, ²The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH
Background/Purpose: In the initial months of the SARS CoV2/COVID19 pandemic, broad use of off-label therapy with hydroxychloroquine (HCQ) was prescribed to reduce CoV2-related morbidity and…
Abstract Number: 0045 • ACR Convergence 2020
Healthcare Practitioner Confidence Assessing Rashes in Patients of Skin of Color with Lupus
Vijay Kannuthurai¹, Jacob Murray², Lisa Zickuhr³ and Ling Chen², ¹Washington University in St. Louis School of Medicine, Hazlehurst, MS, ²Washington University in St. Louis School of Medicine, St. Louis, MO, ³Washington University/B-JH/SLCH Consortium, St. Louis, MO
Background/Purpose: Medical education can promote bias that disproportionately affects patients of color. Patients of color with lupus are especially vulnerable as they often carry a…
Abstract Number: 0443 • ACR Convergence 2020
Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases
Emily Sirotich¹, Teresa Semalulu¹, Kevin Kennedy², Salman Surangiwala³, Maggie Larche¹, Jean Liew⁴, Mitchell Levine², Graeme Reed⁵, Naira Ikram⁶, Carly Harrison⁷, Richard Howard⁸, Rashmi Sinha⁹, Monique Gore-Massy¹⁰ and Jonathan Hausmann¹¹, ¹McMaster University, Hamilton, ON, Canada, ²McMaster University, Hamilton, Canada, ³Queen’s School of Medicine, Kingston, Canada, ⁴University of Washington, Seattle, ⁵Canadian Spondylitis Association, Vancouver, Canada, ⁶Duke University, Durham, ⁷Lupus Chat, NA, ⁸Spondylitis Association of America, Van Nuys, CA, ⁹SJIA Foundation, Cincinnati, ¹⁰Lupus Foundation of America, Brooklyn, NY, ¹¹Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA
Background/Purpose: The COVID-19 pandemic has exacerbated structural and systematic barriers in access to healthcare for racial and ethnic minorities. The impact of these increased barriers…
Abstract Number: 0046 • ACR Convergence 2020
Socioeconomic Disparities in Functional Status Among RA Patients: A Longitudinal Analysis Using RISE Data
Jing Li¹, Gabriela Schmajuk², Michael Evans³, Zara Izadi⁴, Patricia Katz⁵, Alexis Ogdie⁶, Lisa Suter⁷ and Jinoos Yazdany³, ¹University of California, San Francisco, San Francisco, CA, ²University of California, San Francisco, Atherton, CA, ³Ucsf, San Francisco, CA, ⁴University of California San Francisco, San Francisco, CA, ⁵University of California, San Francisco, Novato, CA, ⁶Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ⁷Yale School of Medicine, New Haven, CT
Background/Purpose: Prior studies have shown that RA outcomes, including disease activity, erosions, and disability, are worse among patients with low socioeconomic status (SES). However, few…
Abstract Number: 0574 • ACR Convergence 2020
Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus
Katherine Pryor¹, Chang Xu¹, Jamie Collins¹, Karen Costenbader² and Candace Feldman¹, ¹Brigham and Women's Hospital, Boston, ²Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Hydroxychloroquine/chloroquine (HCQ/CQ) is considered to be the backbone of systemic lupus erythematosus (SLE) care. Differences in receipt of HCQ/CQ may exacerbate disparities in adverse…
Abstract Number: 0047 • ACR Convergence 2020
Administrative Barriers to Enrollment of Ethnic Minorities in Clinical Research of Rheumatic/Immune-Mediated Diseases
Brittany Banbury¹, Sharon Dowell¹, Gail Kerr², Mercedes Quinones², Ginette Okoye¹ and Ilona Jileaeva¹, ¹Howard University Hospital, Washington, DC, ²Washington DC VA Medical Center, Washington, DC
Background/Purpose: Inclusion of ethnic minority subsets in clinical research remains subpar despite mandates for increased participation. Lack of trust, cultural sensitivity and bias, stereotyping, health…
Abstract Number: 0575 • ACR Convergence 2020
The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus
Jessica Williams¹, Weixing Huang², Jamie Collins³, Kreager Taber¹, Katherine McLaughlin¹, Rebecca Cunningham¹, Christine Vogeli⁴, Lisa Wichmann¹ and Candace Feldman³, ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, ³Brigham and Women's Hospital, Boston, ⁴Massachusetts General Hospital, Boston, MA
Background/Purpose: Patients with systemic lupus erythematosus (SLE) are often members of disadvantaged groups and some struggle with high acute care utilization and missed outpatient appointments.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].